Ingalls & Snyder LLC’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,882
| Closed | -$231K | – | 459 |
|
|
2023
Q3 | $231K | Sell |
10,882
-26,803
| -71% | -$697K | 0.01% | 384 |
|
|
2023
Q2 | $1.25M | Sell |
37,685
-1,236
| -3% | -$45.5K | 0.06% | 186 |
|
|
2023
Q1 | $1.53M | Sell |
38,921
-915
| -2% | -$38K | 0.08% | 160 |
|
|
2022
Q4 | $1.68M | Sell |
39,836
-1,960
| -5% | -$75.4K | 0.09% | 147 |
|
|
2022
Q3 | $1.4M | Sell |
41,796
-360
| -0.9% | -$15K | 0.08% | 159 |
|
|
2022
Q2 | $1.82M | Sell |
42,156
-1,315
| -3% | -$60.4K | 0.1% | 150 |
|
|
2022
Q1 | $2.08M | Sell |
43,471
-1,035
| -2% | -$51.3K | 0.09% | 152 |
|
|
2021
Q4 | $2.26M | Sell |
44,506
-3,936
| -8% | -$175K | 0.1% | 150 |
|
|
2021
Q3 | $1.96M | Sell |
48,442
-1,113
| -2% | -$56.3K | 0.09% | 162 |
|
|
2021
Q2 | $2.81M | Sell |
49,555
-5,175
| -9% | -$295K | 0.12% | 136 |
|
|
2021
Q1 | $2.9M | Buy |
54,730
+2,441
| +5% | +$133K | 0.14% | 126 |
|
|
2020
Q4 | $2.86M | Sell |
52,289
-553
| -1% | -$29.1K | 0.14% | 122 |
|
|
2020
Q3 | $2.65M | Sell |
52,842
-4,300
| -8% | -$204K | 0.18% | 101 |
|
|
2020
Q2 | $2.19M | Sell |
57,142
-2,244
| -4% | -$72.1K | 0.13% | 127 |
|
|
2020
Q1 | $1.3M | Buy |
59,386
+6,009
| +11% | +$181K | 0.09% | 162 |
|
|
2019
Q4 | $2.19M | Buy |
53,377
+25
| +0% | +$1.02K | 0.12% | 134 |
|
|
2019
Q3 | $2.27M | Buy |
53,352
+860
| +2% | +$36.1K | 0.11% | 145 |
|
|
2019
Q2 | $2.59M | Sell |
52,492
-6
| -0% | -$305 | 0.12% | 134 |
|
|
2019
Q1 | $2.51M | Buy |
52,498
+3,365
| +7% | +$204K | 0.12% | 134 |
|
|
2018
Q4 | $3.01M | Sell |
49,133
-137
| -0.3% | -$9.24K | 0.16% | 113 |
|
|
2018
Q3 | $4.06M | Buy |
49,270
+20
| +0% | +$1.59K | 0.17% | 110 |
|
|
2018
Q2 | $3.85M | Sell |
49,250
-1,201
| -2% | -$93K | 0.18% | 105 |
|
|
2018
Q1 | $3.72M | Buy |
50,451
+30
| +0.1% | +$2.13K | 0.18% | 106 |
|
|
2017
Q4 | $3.44M | Sell |
50,421
-2,569
| -5% | -$166K | 0.16% | 110 |
|
|
2017
Q3 | $3.26M | Sell |
52,990
-552
| -1% | -$33.9K | 0.17% | 101 |
|
|
2017
Q2 | $3.37M | Sell |
53,542
-304
| -0.6% | -$17.3K | 0.18% | 94 |
|
|
2017
Q1 | $2.99M | Buy |
53,846
+105
| +0.2% | +$5.41K | 0.16% | 106 |
|
|
2016
Q4 | $2.57M | Buy |
53,741
+3,315
| +7% | +$186K | 0.14% | 117 |
|
|
2016
Q3 | $3.27M | Sell |
50,426
-2,064
| -4% | -$116K | 0.18% | 99 |
|
|
2016
Q2 | $2.42M | Sell |
52,490
-3,992
| -7% | -$161K | 0.14% | 113 |
|
|
2016
Q1 | $2.16M | Sell |
56,482
-55,630
| -50% | -$1.84M | 0.14% | 111 |
|
|
2015
Q4 | $4.25M | Sell |
112,112
-1,353
| -1% | -$49.9K | 0.27% | 73 |
|
|
2015
Q3 | $4.68M | Buy |
113,465
+7,285
| +7% | +$313K | 0.31% | 66 |
|
|
2015
Q2 | $5M | Buy |
106,180
+5,415
| +5% | +$293K | 0.28% | 70 |
|
|
2015
Q1 | $6.07M | Buy |
100,765
+36,496
| +57% | +$1.86M | 0.33% | 64 |
|
|
2014
Q4 | $2.81M | Buy |
64,269
+58,984
| +1,116% | +$2.6M | 0.16% | 103 |
|
|
2014
Q3 | $237K | Buy |
+5,285
| New | +$281K | 0.01% | 330 |
|
Other funds holding NUS
Ingalls & Snyder LLC's NUS Position: Q4 2023 in Review
Ingalls & Snyder LLC sold out of Nu Skin (NUS) in Q4 2023, closing a stake of 10,882 shares — an estimated $231K sold.
Ingalls & Snyder LLC first reported a position in NUS in Q3 2014 and held it in 37 quarters. The position peaked at $6.07M in Q1 2015. 212 funds tracked by Wall St. Rank hold NUS as of Q4 2023.
- Ingalls & Snyder LLC reported no remaining Nu Skin position as of Q4 2023 after selling out during the quarter.
- Ingalls & Snyder LLC sold 10,882 Nu Skin shares in Q4 2023, an estimated $231K.
- Ingalls & Snyder LLC first reported a position in Nu Skin in Q3 2014 and held it in 37 quarters.
- Ingalls & Snyder LLC's Nu Skin position peaked at $6.07M in Q1 2015.
- 212 funds tracked by Wall St. Rank held Nu Skin as of Q4 2023.
Based on Ingalls & Snyder LLC's 13F filing for Q4 2023, filed 29 Jan 2024.